Clinical Trial Update: CyberKnife Dose Escalation Prostate Cancer Trial [NA]

View source ↗

Summary

This document reports an ongoing CyberKnife dose-escalation trial for prostate cancer that is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer
• Prostate Neoplasms

Snippet

Sponsor: Crozer-Keystone Health System | Conditions: Prostate Cancer, Prostate Adenocarcinoma | NA | Status: ACTIVE_NOT_RECRUITING